{"id":"https://openalex.org/W1998742987","doi":"https://doi.org/10.3111/13696990802354683","title":"Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia","display_name":"Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W1998742987","doi":"https://doi.org/10.3111/13696990802354683","mag":"1998742987","pmid":"https://pubmed.ncbi.nlm.nih.gov/19450068"},"language":"en","primary_location":{"id":"doi:10.3111/13696990802354683","doi":"https://doi.org/10.3111/13696990802354683","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696990802354683","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696990802354683?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696990802354683?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024200227","display_name":"Lusine Breitscheidel","orcid":"https://orcid.org/0000-0002-5868-5271","observed_orcids":["https://orcid.org/0000-0002-5868-5271"]},"institutions":[{"id":"https://openalex.org/I4405260893","display_name":"Institut f\u00fcr Medizinische Informationsverarbeitung, Biometrie und Epidemiologie","ror":"https://ror.org/04eb1yz45","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405260893","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Lusine Breitscheidel","raw_affiliation_strings":["University of Munich, Department of Medical Informatics, Biometrics and Epidemiology, Munich, Germany. breitscheidel.lusine@kendle.com","Kendle, Munich, Germany","University of Munich, Department of Medical informatics, Biometrics and Epidemiology (IBE), Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Munich, Department of Medical Informatics, Biometrics and Epidemiology, Munich, Germany. breitscheidel.lusine@kendle.com","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"Kendle, Munich, Germany","institution_ids":[]},{"raw_affiliation_string":"University of Munich, Department of Medical informatics, Biometrics and Epidemiology (IBE), Munich, Germany","institution_ids":["https://openalex.org/I4405260893","https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5024200227"],"corresponding_institution_ids":["https://openalex.org/I4405260893","https://openalex.org/I8204097"],"apc_list":null,"apc_paid":null,"fwci":2.1607,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.9018953,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"4","first_page":"571","last_page":"584"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/matched-unrelated-donor","display_name":"matched unrelated donor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8799999952316284},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8870000243186951},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.824999988079071},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.5730000138282776},{"id":"https://openalex.org/keywords/direct-medical-costs","display_name":"direct medical costs","score":0.6970000267028809},{"id":"https://openalex.org/keywords/statutory-health-insurance","display_name":"statutory health insurance","score":0.6539999842643738},{"id":"https://openalex.org/keywords/young-adult-patient","display_name":"young adult patient","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9345517158508301},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7304751873016357},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5926336646080017},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5595765709877014},{"id":"https://openalex.org/C2993416501","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myeloid leukaemia","level":2,"score":0.522609531879425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4616832137107849},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.45787757635116577},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.4225562810897827},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4087260961532593},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.1688314974308014},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005858","descriptor_name":"Germany","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3111/13696990802354683","doi":"https://doi.org/10.3111/13696990802354683","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696990802354683","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696990802354683?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},{"id":"pmid:19450068","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19450068","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical economics","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.3111/13696990802354683","doi":"https://doi.org/10.3111/13696990802354683","is_oa":true,"landing_page_url":"https://doi.org/10.3111/13696990802354683","pdf_url":"https://www.tandfonline.com/doi/pdf/10.3111/13696990802354683?needAccess=true","source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1998742987.pdf","grobid_xml":"https://content.openalex.org/works/W1998742987.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W51583988","https://openalex.org/W78448131","https://openalex.org/W1518153033","https://openalex.org/W1967550009","https://openalex.org/W1976432754","https://openalex.org/W2015905880","https://openalex.org/W2016524375","https://openalex.org/W2032274468","https://openalex.org/W2042961427","https://openalex.org/W2055198551","https://openalex.org/W2058869614","https://openalex.org/W2072115506","https://openalex.org/W2092508198","https://openalex.org/W2099236061","https://openalex.org/W2104877035","https://openalex.org/W2107268345","https://openalex.org/W2118032143","https://openalex.org/W2120756704","https://openalex.org/W2140134889","https://openalex.org/W2148033005","https://openalex.org/W2151486690","https://openalex.org/W2151600819","https://openalex.org/W2182805385","https://openalex.org/W2254382450","https://openalex.org/W2255634377","https://openalex.org/W2291605212","https://openalex.org/W2297214684","https://openalex.org/W2394844371"],"related_works":["https://openalex.org/W2032274468","https://openalex.org/W1976432754","https://openalex.org/W2549959390","https://openalex.org/W2148033005","https://openalex.org/W2055198551","https://openalex.org/W2549851212","https://openalex.org/W2066626240","https://openalex.org/W2343082747","https://openalex.org/W35367245","https://openalex.org/W2563987165"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"estimate,":[2],"from":[3],"the":[4,7,12,41,52,156,167,234],"perspective":[5],"of":[6,15,51,55,85,106,128,169,195,208,233],"German":[8],"statutory":[9],"health":[10],"insurance,":[11],"cost":[13,54,126,154,206],"utility":[14,207],"allogeneic":[16],"stem":[17],"cell":[18],"transplantation":[19],"with":[20,43,87,141,148,215,231],"matched":[21],"unrelated":[22],"donor":[23],"(MUD-SCT)":[24],"in":[25,145,152,159,185,213],"newly":[26],"diagnosed,":[27],"chronic-phase":[28],"chronic":[29],"myeloid":[30],"leukaemia":[31],"(CML)":[32],"patients":[33,147,214],"aged":[34],"40":[35],"years":[36,84],"or":[37,226],"younger,":[38],"relative":[39],"to":[40,139,155,166,210,228],"treatment":[42,86,140,150],"imatinib.":[44,142,170],"METHODS:":[45],"The":[46,80,161,172,192,205],"incremental":[47,104],"cost-effectiveness":[48],"ratio":[49],"(ICER)":[50],"additional":[53],"imatinib":[56,109,176,235],"versus":[57,114],"MUD-SCT":[58,209],"per":[59,111,197],"quality-adjusted":[60],"life":[61],"year":[62,97],"(QALY)":[63],"gained":[64,113,144],"was":[65,72,118],"chosen":[66],"as":[67],"a":[68,75,188,216],"target":[69],"assessment.":[70],"ICER":[71,194],"quantified":[73],"using":[74],"Markov":[76],"cohort":[77],"modelling":[78],"approach.":[79],"evaluation":[81],"encompassed":[82],"5":[83,124],"either":[88,149],"approach,":[89],"and":[90,132,221],"only":[91],"direct":[92],"medical":[93],"costs":[94,105],"(in":[95],"euro,":[96],"2005)":[98],"were":[99,103,130,163],"considered.":[100],"RESULTS:":[101],"There":[102],"euro77,410":[107,196],"for":[108,219],"therapy":[110],"QALY":[112,134,198],"MUD-SCT.":[115],"No":[116],"strategy":[117],"clearly":[119],"dominant;":[120],"on":[121],"average,":[122],"during":[123],"years,":[125],"savings":[127],"euro63,433":[129],"obtained":[131],"0.82":[133],"lost":[135],"by":[136],"SCT":[137],"compared":[138],"QALYs":[143],"CML":[146,212],"resulted":[151],"considerable":[153],"third-party":[157],"payer":[158],"Germany.":[160],"results":[162],"particularly":[164],"sensitive":[165],"price":[168],"CONCLUSIONS:":[171],"analysis":[173],"finds":[174],"that":[175,232],"is":[177,199],"more":[178,181],"costly":[179],"but":[180],"effective":[182],"(as":[183],"measured":[184],"QALYs)":[186],"over":[187],"5-year":[189],"time":[190],"horizon.":[191],"resulting":[193],"higher":[200],"than":[201],"commonly":[202],"cited":[203],"thresholds.":[204],"treat":[211],"European":[217],"Group":[218],"Blood":[220],"Marrow":[222],"Transplantation":[223],"score":[224],"<":[225],"=":[227],"2":[229],"compares":[230],"strategy.":[236]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}